Loading...
Many interventional cardiologists use bare-metal stents (BMS) in large coronary arteries to minimize the possible risk for late stent thrombosis associated with drug-eluting stents (DES), reserving DES for small vessels to minimize the risk for target-vessel revascularization (TVR). To compare the risks and benefits of DES and BMS in large coronary arteries, investigators for the European BASKET-PROVE study randomized 2314 patients requiring stents between 3 and 4 mm in diameter to receive first-generation sirolimus-eluting stents (SES), second-generation everolimus-eluting stents (EES), or cobalt-chromium BMS. Thirty-two percent of participants had ST-segment-elevation myocardial infarction (MI), 43% had multivessel disease, and 76% had an…